Beam Therapeutics Inc. (BEAM) Insider Trading
Over the last 3 months, BEAM insiders made 0 open-market buys and 6 sales, a net sale of -$2.0M (SEC Form 4). Over the last 6 months, 184 institutions increased and 127 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
6
Net (3m)
-$2.0M
Insider trades by month Buys Sells
Jul
Aug
Oct
Jan
Feb
Apr
Context3-month price +43.6%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 22, 2026 | Ciaramella Giuseppeofficer: President | Option | 6,505 | $0.67 |
| Jun 22, 2026 | Ciaramella Giuseppeofficer: President | Option | 29,000 | $1.03 |
| Jun 5, 2026 | Fishman Markdirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | COOPER GRAHAM Kdirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | MARAGANORE JOHNdirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | Guindo Chirfidirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | Shaw Christidirector | Grant | 19,676 | $29.55 |
| Jun 5, 2026 | Walsh Kathleen Edirector | Grant | 19,676 | $29.55 |
| Apr 6, 2026 | Bellon Christineofficer: Chief Legal Officer | Sell | 5,956 | $24.58 |
| Apr 6, 2026 | Simon Amyofficer: Chief Medical Officer | Sell | 6,700 | $24.58 |
| Apr 6, 2026 | Evans John M.director, officer: CEO | Sell | 30,078 | $24.58 |
| Apr 6, 2026 | Ciaramella Giuseppeofficer: President | Sell | 11,810 | $24.58 |
| Apr 6, 2026 | Cavanagh Bethany Jofficer: SVP, Finance and Treasurer | Sell | 3,242 | $24.58 |
| Apr 2, 2026 | Cavanagh Bethany Jofficer: SVP, Finance and Treasurer | Grant | 20,000 | — |
| Apr 2, 2026 | Simon Amyofficer: Chief Medical Officer | Grant | 31,750 | — |
| Apr 2, 2026 | Ciaramella Giuseppeofficer: President | Grant | 40,000 | — |
| Apr 2, 2026 | Bellon Christineofficer: Chief Legal Officer | Grant | 20,000 | — |
| Apr 2, 2026 | Emany Sravan Kumarofficer: Chief Financial Officer | Grant | 31,750 | — |
| Apr 1, 2026 | Evans John M.director, officer: CEO | Option | 25,000 | $0.67 |
| Apr 1, 2026 | Evans John M.director, officer: CEO | Grant | 90,000 | — |
| Apr 1, 2026 | Evans John M.director, officer: CEO | Sell | 25,000 | $22.37 |
| Feb 26, 2026 | Ciaramella Giuseppeofficer: President | Sell | 35,000 | $32.00 |
| Feb 26, 2026 | Ciaramella Giuseppeofficer: President | Option | 35,000 | $17.00 |
| Feb 2, 2026 | Evans John M.director, officer: CEO | Option | 19,336 | $0.67 |
| Feb 2, 2026 | Ciaramella Giuseppeofficer: President | Grant | 80,000 | $27.62 |
| Feb 2, 2026 | Simon Amyofficer: Chief Medical Officer | Grant | 88,500 | $27.62 |
| Feb 2, 2026 | Evans John M.director, officer: CEO | Option | 5,664 | $0.67 |
| Feb 2, 2026 | Evans John M.director, officer: CEO | Option | 25,000 | $0.67 |
| Feb 2, 2026 | Evans John M.director, officer: CEO | Grant | 180,000 | $27.62 |
| Feb 2, 2026 | Evans John M.director, officer: CEO | Sell | 2,906 | $29.00 |
Source: BEAM SEC Form 4 filings, latest Jun 22, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their BEAM positions over the last 6 months (SEC Form 13F).
Increased
184
New positions
108
Reduced
127
Sold out
73
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | Increased | 12.5M | Feb 11, 2026 |
| FMR LLC | Increased | 12.5M | May 15, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | Reduced | 12.1M | May 12, 2026 |
| FMR LLC | Increased | 11.9M | Feb 17, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 10.1M | May 15, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 10.1M | Feb 17, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Unchanged | 10.1M | Feb 17, 2026 |
| VANGUARD GROUP INC | Reduced | 9.2M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 8.8M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 8.5M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 8.5M | Feb 12, 2026 |
| STATE STREET CORP | Increased | 5.7M | May 15, 2026 |
| STATE STREET CORP | Increased | 5.2M | Feb 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4.6M | May 8, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 4.5M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.